MTOR and cancer: The genetic variants described in our study belong to some of the most common key cancer regulatory networks in solid tumors, such as the RAS/RAF/MAPK and PI3K/AKT/mTOR signaling pathways, the DNA damage repair (DDR) pathways, and cell cycle checkpoints.